Related Articles
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: An EORTC Receptor and Biomarker Group collaboration
Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: Comparison to antigen quantification by ELISA
Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids
Urokinase-type plasminogen activator system and breast cancer (Review)